Revision history of "The COVIRL002 TrialTocilizumab regarding treatments for significant noncritical COVID19 an infection An organized review of a study protocol for the randomised controlled tryout"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 08:32, 5 February 2024‎ Atmepoch2 (Talk | contribs)‎ . . (3,817 bytes) (+3,817)‎ . . (Created page with "A total of 478 individuals along with myelopathy due to cervical OPLL via Twenty eight establishments were prospectively signed up through 2014 to be able to 2017 along with a...")
Retrieved from "http://eechcentral.simhq.com/index.php?title=The_COVIRL002_TrialTocilizumab_regarding_treatments_for_significant_noncritical_COVID19_an_infection_An_organized_review_of_a_study_protocol_for_the_randomised_controlled_tryout"